Esperion Therapeutics
ESPR
#8331
Rank
โ‚ฌ0.14 B
Marketcap
0,74ย โ‚ฌ
Share price
-10.32%
Change (1 day)
-58.68%
Change (1 year)

Revenue for Esperion Therapeutics (ESPR)

Revenue in 2024 (TTM): โ‚ฌ0.30 Billion

According to Esperion Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.28 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Esperion Therapeutics from 2000 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.31 B203.46%
2023 โ‚ฌ0.10 B49.56%
2022 โ‚ฌ70.36 M1.58%
2021 โ‚ฌ69.26 M-62.56%
2020 โ‚ฌ0.18 B39.68%
2019 โ‚ฌ0.13 B
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2000 โ‚ฌ0 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.48 B 68.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.47 B 758.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ55.25 B 19,046.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.33 B 4,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.45 B 58.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ26.99 M-90.65%๐Ÿ‡บ๐Ÿ‡ธ USA